Last reviewed: June 7, 2026
Last updated: June 7, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 medications activate hormone pathways that reduce hunger and improve blood sugar control, leading to average weight losses of 15-22% over 68 weeks in clinical trials. If you're considering a weight loss program in 2026, understanding how GLP-1 therapy works—and whether it fits your health profile—is essential before starting. PlexusDx offers compounded GLP-1 options for patients across all 50 states without insurance requirements.
How GLP-1 Weight Loss Medications Work in Your Body
GLP-1 (glucagon-like peptide-1) is a natural hormone your gut produces when you eat. It signals your brain's appetite center to reduce hunger, slows stomach emptying so you feel full longer, and helps regulate blood sugar. Semaglutide and tirzepatide mimic this hormone, making your body think it's already satisfied with smaller portions.
When you start a GLP-1 program, your medication gradually suppresses ghrelin (the hunger hormone) while increasing satiety signals. Most patients notice reduced cravings within 3-7 days and eat 30-40% fewer calories without feeling deprived. This biological shift is what sets GLP-1 therapy apart from traditional diet-and-exercise approaches alone.
Semaglutide vs. Tirzepatide: Which Medication Suits You
Semaglutide targets GLP-1 receptors exclusively, making it a single-pathway therapy with a well-established safety profile. Tirzepatide activates both GLP-1 and GIP receptors simultaneously, engaging dual hormone pathways for potentially greater weight loss—studies show tirzepatide users lose 21-25% of body weight compared to 15-22% with semaglutide alone.
Your choice depends on your genetics, medical history, and weight loss goals. PlexusDx's Precision Peptide Genetic Test identifies your sensitivity to key variants in GLP1R, GIPR, FTO, and MC4R genes, revealing which compound may work best for your peptide pathways. Compounded semaglutide injections start at $149/month, while compounded tirzepatide injections begin at $249/month—your dose may need to go up over time, but your price won't.
Expected Timeline and Weight Loss Results from GLP-1 Therapy
Most patients on GLP-1 programs experience their first weight loss results within 2-4 weeks as appetite suppression begins. By week 12, the average person loses 5-10% of their starting weight; by week 24, losses reach 10-15%. Peak results typically occur between months 6-9, with total weight reduction stabilizing in that range unless dosing is increased.
Results vary based on starting weight, metabolism, medication adherence, and whether you maintain healthy eating habits. Someone starting at 250 pounds might lose 40-50 pounds over six months, while someone at 180 pounds might lose 25-35 pounds in the same timeframe. PlexusDx tracks your progress through your provider portal so adjustments can be made if your results plateau.
Starting Your GLP-1 Program: Cost, Access, and Getting Approved
PlexusDx serves all 50 states and requires no insurance, no membership fees, and no prior authorization delays. Compounded semaglutide injections are available starting at $149 per month, while oral semaglutide begins at $249 per month. Both formulations are prepared by licensed 503A compounding pharmacies, ensuring pharmaceutical-grade purity and potency. HSA and FSA accounts are eligible for payment, reducing your out-of-pocket cost.
Your first step is a telehealth consultation with a PlexusDx provider who reviews your weight history, medications, and health conditions to determine if GLP-1 therapy is appropriate. If approved, you receive your first shipment within 5-7 business days. Optional: after your first month of treatment, you can add the Precision Peptide Genetic Test ($99) to map your peptide pathways across 14 hormone systems and 49 peptides, uncovering 150+ personalized insights for long-term success.
Common Side Effects and How to Minimize Them
Most side effects from GLP-1 therapy are mild and temporary—nausea, constipation, and reduced appetite for foods you normally enjoy are the most frequent complaints. These typically peak in weeks 2-4 and fade as your body adjusts. Staying hydrated, eating smaller meals, and increasing fiber gradually can ease gastrointestinal symptoms significantly.
Serious side effects like pancreatitis or gallbladder complications are rare in clinical use. PlexusDx providers screen for contraindications (personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2) before prescribing. If you experience severe abdominal pain, persistent vomiting, or signs of dehydration, contact your provider immediately—these warrant dose adjustment or temporary pause in therapy.
Maintaining Your Weight Loss After Stopping GLP-1
Weight regain is a real concern after discontinuing GLP-1 therapy—studies show that without ongoing treatment, patients regain 50-75% of lost weight within one year. This doesn't mean the therapy failed; it reflects your body's natural tendency to return to baseline hunger signals once the medication is removed. Some patients maintain results long-term by staying on a lower dose as a maintenance strategy.
PlexusDx providers work with you to develop a sustainable plan: some patients continue therapy indefinitely at a reduced dose, while others combine GLP-1 with structured nutrition coaching and fitness support to lock in results. Genetic insights from the Precision Peptide Test reveal your individual susceptibility to weight rebound, helping your care team design a personalized exit or maintenance strategy that works for your metabolism.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Do I need a gym membership or strict diet to succeed on GLP-1 therapy?
No. GLP-1 medications work through biology, not willpower—appetite suppression alone drives weight loss. While regular movement and balanced nutrition amplify results, most patients lose significant weight on medication alone. PlexusDx recommends combining therapy with sustainable habit changes rather than extreme restriction, which increases long-term success rates.
How quickly will I see weight loss results on semaglutide?
Most patients notice reduced appetite within 3-7 days and measurable weight loss by week 2-4. Average results reach 5-10% body weight loss by 12 weeks and 15-22% by 6 months. Individual timelines vary based on starting weight, dose, and adherence—your PlexusDx provider tracks progress and adjusts dosing to optimize results.
Is compounded GLP-1 from PlexusDx as safe and effective as brand-name semaglutide?
Yes. PlexusDx compounded medications are prepared by licensed 503A compounding pharmacies using pharmaceutical-grade active ingredients, following the same FDA standards as brand medications. The active compound is identical; compounding allows flexible dosing and lower cost. Effectiveness studies show compounded and brand versions produce comparable weight loss outcomes.
What happens if I gain weight back after stopping GLP-1 treatment?
Weight regain is common after discontinuing GLP-1 because appetite hormones return to baseline. Many patients choose long-term maintenance therapy at a lower dose to sustain results. Your PlexusDx provider can help you decide whether to continue treatment, combine it with lifestyle coaching, or transition to a maintenance plan based on your genetic predispositions and goals.
How does the Precision Peptide Genetic Test help personalize my GLP-1 therapy?
PlexusDx's Precision Peptide Genetic Test ($99) analyzes 14 hormone pathways and 49 peptides, revealing genetic variants that influence your response to GLP-1 and GIP receptor agonists. Key variants in GLP1R, GIPR, FTO, and MC4R help predict whether semaglutide or tirzepatide may work better for your body, guiding your provider's medication selection and dosing strategy for faster, more personalized results.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Happens When You Stop Taking GLP-1 for Weight Loss?
Why Am I Not Losing Weight on GLP-1: Understanding the Factors at Play